# Fifth District Bancorp, Inc.: financial statements, quarterly

FDSB · Nasdaq · CIK 2012726 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fdsb.md) · [Financials](/companies/fdsb/financials.md) · [Filings](/companies/fdsb/filings.md) · [Insiders](/companies/fdsb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fdsb/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $k | [10.0](/filings/0001558370-24-015737.md) | [(15.0) d](/filings/0001558370-25-003713.md) | [(301)](/filings/0001558370-25-007593.md) | [182](/filings/0001558370-25-011234.md) | [(210)](/filings/0001104659-25-109288.md) | [(29.0) d](/filings/0001104659-26-033945.md) | [21.0](/filings/0001104659-26-059501.md) | [(91.0)](/filings/0001104659-26-093464.md) | [91.0](/filings/0001104659-25-109288.md) | [76.0 d](/filings/0001104659-26-033945.md) | [103](/filings/0001104659-26-059501.md) | [101](/filings/0001104659-26-093464.md) |
| Net income | $k | [39.0](/filings/0001558370-24-015737.md) | [178 d](/filings/0001558370-25-003713.md) | [(1,132)](/filings/0001558370-25-007593.md) | [683](/filings/0001558370-25-011234.md) | [(788)](/filings/0001104659-25-109288.md) | [159 d](/filings/0001104659-26-033945.md) | [78.0](/filings/0001104659-26-059501.md) | [3,126](/filings/0001104659-26-093464.md) | [343](/filings/0001104659-25-109288.md) | [541 d](/filings/0001104659-26-033945.md) | [387](/filings/0001104659-26-059501.md) | [384](/filings/0001104659-26-093464.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.15)](/filings/0001104659-25-109288.md) | not reported | [0.02](/filings/0001104659-26-059501.md) | [0.61](/filings/0001104659-26-093464.md) | [0.07](/filings/0001104659-25-109288.md) | not reported | [0.08](/filings/0001104659-26-059501.md) | [0.08](/filings/0001104659-26-093464.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | [(0.15)](/filings/0001104659-25-109288.md) | not reported | [0.02](/filings/0001104659-26-059501.md) | [0.61](/filings/0001104659-26-093464.md) | [0.07](/filings/0001104659-25-109288.md) | not reported | [0.08](/filings/0001104659-26-059501.md) | [0.08](/filings/0001104659-26-093464.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [19.3](/filings/0001558370-25-003713.md) | [36.6](/filings/0001558370-24-009435.md) | [46.2](/filings/0001558370-24-012255.md) | [34.1](/filings/0001558370-24-015737.md) | [37.9](/filings/0001104659-26-033945.md) | [30.1](/filings/0001558370-25-007593.md) | [27.7](/filings/0001558370-25-011234.md) | [34.4](/filings/0001104659-25-109288.md) | [33.9](/filings/0001104659-26-093464.md) | [23.3](/filings/0001104659-26-059501.md) | [19.2](/filings/0001104659-26-093464.md) |
| Total assets | $m | not reported | [481](/filings/0001558370-25-003713.md) | [486](/filings/0001558370-24-009435.md) | [516](/filings/0001558370-24-012255.md) | [524](/filings/0001558370-24-015737.md) | [527](/filings/0001104659-26-033945.md) | [531](/filings/0001558370-25-007593.md) | [540](/filings/0001558370-25-011234.md) | [540](/filings/0001104659-25-109288.md) | [534](/filings/0001104659-26-093464.md) | [536](/filings/0001104659-26-059501.md) | [532](/filings/0001104659-26-093464.md) |
| Total liabilities | $m | not reported | [403](/filings/0001558370-25-003713.md) | [409](/filings/0001558370-24-009435.md) | [438](/filings/0001558370-24-012255.md) | [396](/filings/0001558370-24-015737.md) | [402](/filings/0001104659-26-033945.md) | [404](/filings/0001558370-25-007593.md) | [409](/filings/0001558370-25-011234.md) | [408](/filings/0001104659-25-109288.md) | [405](/filings/0001104659-26-093464.md) | [406](/filings/0001104659-26-059501.md) | [403](/filings/0001104659-26-093464.md) |
| Shareholders' equity | $m | [74.9](/filings/0001558370-24-015737.md) | [77.8](/filings/0001104659-26-033945.md) | [77.0](/filings/0001558370-25-011234.md) | [78.0](/filings/0001104659-25-109288.md) | [128](/filings/0001104659-25-109288.md) | [126](/filings/0001104659-26-093464.md) | [127](/filings/0001104659-26-093464.md) | [131](/filings/0001104659-26-093464.md) | [131](/filings/0001104659-25-109288.md) | [130](/filings/0001104659-26-093464.md) | [129](/filings/0001104659-26-093464.md) | [129](/filings/0001104659-26-093464.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [386 d](/filings/0001558370-24-015737.md) | [(537) d](/filings/0001558370-25-003713.md) | [(770)](/filings/0001558370-25-007593.md) | [(385) d](/filings/0001558370-25-011234.md) | [734 d](/filings/0001104659-25-109288.md) | [(633) d](/filings/0001104659-26-033945.md) | [823](/filings/0001104659-26-059501.md) | [430 d](/filings/0001104659-26-093464.md) | [117 d](/filings/0001104659-25-109288.md) | [(44.0) d](/filings/0001104659-26-033945.md) | [1,037](/filings/0001104659-26-059501.md) | [862 d](/filings/0001104659-26-093464.md) |
| Capital expenditure | $k | [278 d](/filings/0001558370-24-015737.md) | [700 d](/filings/0001558370-25-003713.md) | [344](/filings/0001558370-25-007593.md) | [116 d](/filings/0001558370-25-011234.md) | [24.0 d](/filings/0001104659-25-109288.md) | [26.0 d](/filings/0001104659-26-033945.md) | [58.0](/filings/0001104659-26-059501.md) | [181 d](/filings/0001104659-26-093464.md) | [63.0 d](/filings/0001104659-25-109288.md) | [82.0 d](/filings/0001104659-26-033945.md) | [301](/filings/0001104659-26-059501.md) | [266 d](/filings/0001104659-26-093464.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,125](/filings/0001104659-25-109288.md) | [5,139](/filings/0001104659-26-059501.md) | [5,145](/filings/0001104659-26-093464.md) | [5,143](/filings/0001104659-25-109288.md) | [4,914](/filings/0001104659-26-059501.md) | [4,870](/filings/0001104659-26-093464.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,235,658 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001104659-26-093464.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.